Gene Sequencer's Investors Say $118M Deal Chilled Other Offers
A putative class of Complete Genomics Inc. shareholders asked a Delaware state judge Wednesday to strike down provisions in the company's $118 million buyout deal that kept other offers off the...To view the full article, register now.
Already a subscriber? Click here to view full article